RA CAPITAL MANAGEMENT, L.P. sold 0.0% of their position (213.00 shares) of VOR BIOPHARMA INC. on the open market
Open‑market sale worth $4.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/21/2026ACC: 0001231919-26-000776
Director10% Owner
Since Feb 2021
-213.00
Net shares
Net seller
$4.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.10M acquired · 2.10M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+2.10M
Price / share
$0.00
Trade value
$4.20K
% of position
87.4%
7/16/2026
2.40M→4.50M
Common Stock
Indirect
Shares
−213.00
Price / share
$19.75
Trade value
$4.21K
% of position
0.0%
7/16/2026
4.50M→4.50M
Total
Net shares
+2.10M
Net value
-$6.75
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/16/2026 | X · X | +2.10M | $0.00 | $4.20K | 87.4% | 2.40M | 4.50M |
| Common Stock Indirect | 7/16/2026 | S · Sale | −213.00 | $19.75 | $4.21K | 0.0% | 4.50M | 4.50M |
| Total | +2.10M | -$6.75 | ||||||
Derivative Transactions1
Pre-Funded Warrant (Right to Buy)
Indirect
Converts to
Common Stock
2.10M shares
Shares
−2.10M
Strike price
0.002
Held after
7.90M
Exercisable
—
7/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrant (Right to Buy) Indirect | Common Stock2.10M shares | 7/16/2026 | X · X | −2.10M | 0.002 | — | 7.90M |